Data / Form D filings / CapsoVision, Inc
CapsoVision, Inc: Form D filings
CapsoVision, Inc, a biotechnology company in Saratoga, CA, filed 17 Form D notices with the SEC between 2009 and 2024. The latest, on July 23, 2024, reports $64.8 million sold of a $64.8 million offering to 114 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18805 COX AVENUE SUITE 250, Saratoga, CA, 95070
- Phone
- (408) 370-4790
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1378325
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 23, 2024 | Amendment | $64,828,840 | $64,828,822 | $18 | 114 | Nov 21, 2019 | sec.gov |
| Oct 19, 2023 | Amendment | $54,828,841 | $54,828,812 | $29 | 105 | Nov 21, 2019 | sec.gov |
| Mar 7, 2023 | Amendment | $41,951,355 | $34,698,838 | $7,252,517 | 51 | Nov 21, 2019 | sec.gov |
| Mar 11, 2021 | Amendment | $20,000,000 | $11,996,358 | $8,003,642 | 24 | Nov 21, 2019 | sec.gov |
| Jun 17, 2020 | New notice | $5,470,000 | $980,000 | $4,490,000 | 7 | May 21, 2020 | sec.gov |
| Nov 26, 2019 | New notice | $10,000,000 | $2,900,004 | $7,099,996 | 5 | Nov 21, 2019 | sec.gov |
| Oct 31, 2018 | New notice | $10,000,000 | $6,058,958 | $3,941,042 | 11 | Aug 16, 2018 | sec.gov |
| Oct 31, 2018 | New notice | $8,000,100 | $8,000,009 | $91 | 8 | Jan 5, 2018 | sec.gov |
| Apr 25, 2016 | New notice | $15,000,000 | $4,599,999 | $10,400,001 | 9 | Mar 2, 2016 | sec.gov |
| Feb 21, 2014 | New notice | $16,100,000 | $15,899,997 | $200,003 | 6 | Jan 23, 2014 | sec.gov |
| Oct 26, 2012 | New notice | $3,707,200 | $3,707,200 | 4 | Oct 9, 2012 | sec.gov | |
| Sep 6, 2012 | New notice | $700,000 | $450,000 | $250,000 | 3 | Aug 20, 2012 | sec.gov |
| Jun 28, 2012 | New notice | $6,089,999 | $589,993 | $5,500,006 | 5 | Jun 12, 2012 | sec.gov |
| Dec 23, 2011 | New notice | $1,999,999 | $1,459,997 | $540,002 | 8 | Dec 22, 2011 | sec.gov |
| Feb 8, 2011 | New notice | $3,450,000 | $2,514,993 | $935,007 | 14 | Jan 31, 2011 | sec.gov |
| Feb 25, 2010 | New notice | $5,000,000 | $2,549,989 | $2,450,011 | 7 | Feb 12, 2010 | sec.gov |
| Aug 5, 2009 | New notice | $1,044,009 | $1,044,009 | 4 | Jul 28, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Heidi Huai Chung | Director | |
| Patty Huai Kuo | Director | |
| M.L. Huai Chen | Director | |
| Eli Huai Harari | Director | |
| Pen-Jung Huai Tseng | Director | |
| Chen Huai Tsai | Director | |
| Howard Huai Lee | Director | |
| Kang Huai Wang | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 22, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CapsoVision, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.